(Q35959464)

11 August 2017

Fecal microbiota transplantation in children: a brief review (English)

1 reference

11 August 2017

0 references

Maria Oliva-Hemker

2

0 references

author name string

Suchitra K Hourigan

series ordinal

1

1 reference

PubMed ID

26982451

11 August 2017

language of work or name

English

0 references

publication date

16 March 2016

1 reference

11 August 2017

1 reference

11 August 2017

80

1 reference

11 August 2017

1

1 reference

11 August 2017

2-6

1 reference

https://scigraph.springernature.com/pub.10.1038/pr.2016.48

11 August 2017

0 references

cites work

Metagenomic analysis of the human distal gut microbiome

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

A human gut microbial gene catalogue established by metagenomic sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Has the microbiota played a critical role in the evolution of the adaptive immune system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

The gut microbiota in IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

A role for the gut microbiota in IBS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Gut microbiome, obesity, and metabolic dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Decreased diversity of the fecal Microbiome in recurrent Clostridium difficile-associated diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Burden of Clostridium difficile infection in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Clostridium difficile infection: epidemiology, risk factors and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Duodenal infusion of donor feces for recurrent Clostridium difficile

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Systematic review: faecal microbiota transplantation therapy for digestive and nondigestive disorders in adults and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Why is initial bacterial colonization of the intestine important to infants' and children's health?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

The human gut microbiota: a dynamic interplay with the host from birth to senescence settled during childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Recent trends in the epidemiology and treatment of C. difficile infection in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Clostridium difficile infection among children across diverse US geographic locations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Novel risk factors for recurrent Clostridium difficile infection in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

The prevalence of Clostridium difficile infection in pediatric and adult patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Recurrence rate of clostridium difficile infection in hospitalized pediatric patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Fecal microbiota transplantation in the treatment of refractory Clostridium difficile infection in children: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Fecal microbiota transplantation via nasogastric tube for recurrent clostridium difficile infection in pediatric patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Fecal transplant for recurrent Clostridium difficile infection in children with and without inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Fecal microbiota transplantation in children with recurrent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Efficacy of fecal microbiota transplantation in 2 children with recurrent Clostridium difficile infection and its impact on their growth and gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Microbiome changes associated with sustained eradication of Clostridium difficile after single faecal microbiota transplantation in children with and without inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Fecal microbiome transplantation for recurrent Clostridium difficile infection: report on a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Asymptomatic colonization by Clostridium difficile in infants: implications for disease in later life

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Clostridium difficile infection in infants and children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Clostridium difficile carriage and serum antitoxin responses in children with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Transient flare of ulcerative colitis after fecal microbiota transplantation for recurrent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Bacteremia as an adverse event of fecal microbiota transplantation in a patient with Crohn's disease and recurrent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Microbiota dynamics in patients treated with fecal microbiota transplantation for recurrent Clostridium difficile infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Toward an understanding of changes in diversity associated with fecal microbiome transplantation based on 16S rRNA gene deep sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Durable alteration of the colonic microbiota by the administration of donor fecal flora

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Recovery of the gut microbiome following fecal microbiota transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Safety, tolerability, and clinical response after fecal transplantation in children and young adults with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Fecal microbial transplant via nasogastric tube for active pediatric ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Serial fecal microbiota transplantation alters mucosal gene expression in pediatric ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Treating Clostridium difficile infection with fecal microbiota transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Time series community genomics analysis reveals rapid shifts in bacterial species, strains, and phage during infant gut colonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Gut microbiota composition correlates with diet and health in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

An obesity-associated gut microbiome with increased capacity for energy harvest

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Altering the Intestinal Microbiota during a Critical Developmental Window Has Lasting Metabolic Consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Weight gain after fecal microbiota transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in Pediatric Patients: Encouragement Wrapped in Caution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Seroprevalence of cytomegalovirus infection in the United States, 1988-1994

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection in a child

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Pediatric severe pseudomembranous enteritis treated with fecal microbiota transplantation in a 13-month-old infant

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Fecal Microbial Transplantation in Early-Onset Colitis: Caution Advised

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2016.48

Epidemiology of recurrences or reinfections of Clostridium difficile-associated diarrhea.

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26982451

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/PR.2016.48

1 reference

PubMed ID

26982451

Dimensions Publication ID

11 August 2017

0 references

1 reference

PubMed ID

26982451